And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation
暂无分享,去创建一个
Dimiter Prodanov | Dries Braeken | Jean Delbeke | Luis Hoffman | J. Delbeke | D. Prodanov | D. Braeken | Luis Hoffman | K. Mols | Katrien Mols | Katrien Mols | L. Hoffman
[1] W. Carlezon,et al. Use of Adeno‐Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice , 2015, Current protocols in neuroscience.
[2] S. Gray,et al. Methods for gene transfer to the central nervous system. , 2014, Advances in genetics.
[3] J. Bennett,et al. A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[4] Hyung Ho Yoon,et al. Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease. , 2014, Neurosurgery.
[5] Patrick Degenaar,et al. A Processing Platform for Optoelectronic/Optogenetic Retinal Prosthesis , 2013, IEEE Transactions on Biomedical Engineering.
[6] I. Soltesz,et al. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy , 2013, Nature Communications.
[7] Christofer Toumazou,et al. Modeling Study of the Light Stimulation of a Neuron Cell With Channelrhodopsin-2 Mutants , 2011, IEEE Transactions on Biomedical Engineering.
[8] Mark A. Rossi,et al. A wirelessly controlled implantable LED system for deep brain optogenetic stimulation , 2015, Front. Integr. Neurosci..
[9] K. Thompson,et al. Overview on Research and Clinical Applications of Optogenetics , 2016, Current protocols in pharmacology.
[10] Ling Wang,et al. Light distribution and thermal effects in the rat brain under optogenetic stimulation , 2016, Journal of biophotonics.
[11] R. Ransohoff,et al. Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.
[12] Dimiter Prodanov,et al. Mechanical and Biological Interactions of Implants with the Brain and Their Impact on Implant Design , 2016, Front. Neurosci..
[13] A. Zorzos,et al. Multiwaveguide implantable probe for light delivery to sets of distributed brain targets. , 2010, Optics letters.
[14] W. C. Hall,et al. High-speed mapping of synaptic connectivity using photostimulation in Channelrhodopsin-2 transgenic mice , 2007, Proceedings of the National Academy of Sciences.
[15] Xindong Liu,et al. Microelectrode array for chronic deep-brain microstimulation and recording , 2006, IEEE Transactions on Biomedical Engineering.
[16] R. Ramakrishnan,et al. Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons , 1998, Gene Therapy.
[17] J. Uney,et al. Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells) , 2009, Cell Biology and Toxicology.
[18] A. Benabid,et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. , 1996, Journal of neurosurgery.
[19] Robert Puers,et al. Low Loss CMOS-Compatible PECVD Silicon Nitride Waveguides and Grating Couplers for Blue Light Optogenetic Applications , 2016, IEEE Photonics Journal.
[20] Richard O. Snyder,et al. Adeno-Associated Virus , 2011, Methods in Molecular Biology.
[21] Eran Stark,et al. Diode probes for spatiotemporal optical control of multiple neurons in freely moving animals. , 2012, Journal of neurophysiology.
[22] Olivier Marre,et al. Red‐shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina , 2016, EMBO molecular medicine.
[23] Donna Webb,et al. Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca++ sensing , 2016, Nature Communications.
[24] J. Volkmann,et al. Introduction to the programming of deep brain stimulators , 2002, Movement disorders : official journal of the Movement Disorder Society.
[25] Jack A. Wells,et al. fMRI response to blue light delivery in the naïve brain: Implications for combined optogenetic fMRI studies , 2013, NeuroImage.
[26] Steve S. Chung,et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy , 2015, Neurology.
[27] Xue Han,et al. In vivo application of optogenetics for neural circuit analysis. , 2012, ACS chemical neuroscience.
[28] James M. Wilson,et al. Gene Therapy Vectors Based on Adeno-Associated Virus Type 1 , 1999, Journal of Virology.
[29] Shriya Srinivasan,et al. Transdermal optogenetic peripheral nerve stimulation , 2017, Journal of neural engineering.
[30] F. Lim,et al. General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination , 2013, Current gene therapy.
[31] Dinh Tuan Vo. Biomedical photonics handbook , 2003 .
[32] E. Barcelon,et al. Optogenetic Glia Manipulation: Possibilities and Future Prospects , 2016, Experimental neurobiology.
[33] Weien Yuan,et al. Current Experimental Studies of Gene Therapy in Parkinson's Disease , 2017, Front. Aging Neurosci..
[34] Michael Z. Lin,et al. Characterization of engineered channelrhodopsin variants with improved properties and kinetics. , 2009, Biophysical journal.
[35] S. Duan,et al. Entorhinal Principal Neurons Mediate Brain-stimulation Treatments for Epilepsy , 2016, EBioMedicine.
[36] Takeharu Nagai,et al. Genetically encoded bioluminescent voltage indicator for multi-purpose use in wide range of bioimaging , 2017, Scientific Reports.
[37] Denise M. Piscopo,et al. Rhythmic brain stimulation reduces anxiety-related behavior in a mouse model based on meditation training , 2017, Proceedings of the National Academy of Sciences.
[38] Jason Chung,et al. Long-term channelrhodopsin-2 (ChR2) expression can induce abnormal axonal morphology and targeting in cerebral cortex , 2013, Front. Neural Circuits.
[39] Christian Hauptmann,et al. Coordinated reset has sustained aftereffects in Parkinsonian monkeys , 2012, Annals of neurology.
[40] M. Häusser,et al. All-Optical Interrogation of Neural Circuits , 2015, The Journal of Neuroscience.
[41] T. Eggerman,et al. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] V. Haurigot,et al. Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[43] J. R. Augustine,et al. Evolution and rebirth of functional stereotaxy in the subthalamus. , 2013, World neurosurgery.
[44] Chethan Pandarinath,et al. Retinal prosthetic strategy with the capacity to restore normal vision , 2012, Proceedings of the National Academy of Sciences.
[45] O. Yoshida,et al. Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity , 2015, Proceedings of the National Academy of Sciences.
[46] Alex J Walsh,et al. Action potential block in neurons by infrared light. , 2016, Neurophotonics.
[47] J. Wickens,et al. Interfacing with Neural Activity via Femtosecond Laser Stimulation of Drug-Encapsulating Liposomal Nanostructures , 2016, eNeuro.
[48] M. Hayden,et al. Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation. , 2006, Human gene therapy.
[49] S. Kleinlogel. Optogenetic user's guide to Opto-GPCRs. , 2016, Frontiers in bioscience.
[50] R. Herzog,et al. Progress and prospects: immune responses to viral vectors , 2010, Gene Therapy.
[51] J. Rasko,et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.
[52] Leonardo Sileo,et al. Micro- and Nanotechnologies for Optical Neural Interfaces , 2016, Front. Neurosci..
[53] Hyung Ho Yoon,et al. Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease , 2016, Stereotactic and Functional Neurosurgery.
[54] Jing Wang,et al. Integrated device for combined optical neuromodulation and electrical recording for chronic in vivo applications , 2012, Journal of neural engineering.
[55] Mohamed S. Emara,et al. Dynamic illumination of spatially restricted or large brain volumes via a single tapered optical fiber , 2017, Nature Neuroscience.
[56] Andrei Faraon,et al. Patterned photostimulation via visible-wavelength photonic probes for deep brain optogenetics , 2016, Neurophotonics.
[57] B. Roska,et al. Emerging therapies for inherited retinal degeneration , 2016, Science Translational Medicine.
[58] R. Herzog,et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. , 2009, Blood.
[59] Katja M Arndt,et al. Strategies for the photo-control of endogenous protein activity. , 2017, Current opinion in structural biology.
[60] P. O'Suilleabhain,et al. Tremor response to polarity, voltage, pulsewidth and frequency of thalamic stimulation , 2003, Neurology.
[61] Niklas Smedemark-Margulies,et al. Tools, methods, and applications for optophysiology in neuroscience , 2013, Front. Mol. Neurosci..
[62] Vinay Goyal,et al. Parkinson's disease: A review , 2018, Neurology India.
[63] Warren M Grill,et al. Implanted neural interfaces: biochallenges and engineered solutions. , 2009, Annual review of biomedical engineering.
[64] Edward B. Miller,et al. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. , 2006, Journal of virology.
[65] Gil Bub,et al. All‐optical control of cardiac excitation: combined high‐resolution optogenetic actuation and optical mapping , 2016, The Journal of physiology.
[66] Pui-In Mak,et al. An Integrated Circuit for Simultaneous Extracellular Electrophysiology Recording and Optogenetic Neural Manipulation , 2017, IEEE Transactions on Biomedical Engineering.
[67] B. Pál,et al. Astrocyte-Dependent Slow Inward Currents (SICs) Participate in Neuromodulatory Mechanisms in the Pedunculopontine Nucleus (PPN) , 2017, Front. Cell. Neurosci..
[68] M. Clyde,et al. Clinical response to varying the stimulus parameters in deep brain stimulation for essential tremor , 2006, Movement disorders : official journal of the Movement Disorder Society.
[69] Steffen B. E. Wolff,et al. A polymer-based neural microimplant for optogenetic applications: design and first in vivo study. , 2013, Lab on a chip.
[70] Thomas J. Davidson,et al. Bidirectional Control of Generalized Epilepsy Networks via Rapid Real-Time Switching of Firing Mode , 2017, Neuron.
[71] S. Randell,et al. Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9* , 2011, The Journal of Biological Chemistry.
[72] K. Eliceiri,et al. Blue Light Modulates Murine Microglial Gene Expression in the Absence of Optogenetic Protein Expression , 2016, Scientific Reports.
[73] A. Rezai,et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial , 2011, The Lancet Neurology.
[74] M. Fee,et al. Using temperature to analyze temporal dynamics in the songbird motor pathway , 2008, Nature.
[75] Christoph Zrenner,et al. Closed-Loop Neuroscience and Non-Invasive Brain Stimulation: A Tale of Two Loops , 2016, Front. Cell. Neurosci..
[76] Kishan Dholakia,et al. Fast targeted gene transfection and optogenetic modification of single neurons using femtosecond laser irradiation , 2013, Scientific Reports.
[77] Murtaza Z Mogri,et al. Optical Deconstruction of Parkinsonian Neural Circuitry , 2009, Science.
[78] R. H. Smith. Adeno-associated virus integration: virus versus vector , 2008, Gene Therapy.
[79] Keyun Qing,et al. Adeno-associated virus 2 co-receptors?-first reply , 1999, Nature Medicine.
[80] Karl Deisseroth,et al. Closed-Loop and Activity-Guided Optogenetic Control , 2015, Neuron.
[81] N. Bessis,et al. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms , 2004, Gene therapy.
[82] E. Bamberg,et al. Channelrhodopsin-1: A Light-Gated Proton Channel in Green Algae , 2002, Science.
[83] K. Suk,et al. Reversible Induction of Pain Hypersensitivity following Optogenetic Stimulation of Spinal Astrocytes. , 2016, Cell reports.
[84] Charles B. Mikell,et al. Deep brain stimulation: a mechanistic and clinical update. , 2013, Neurosurgical focus.
[85] J. French,et al. Refractory Epilepsy: One Size Does Not Fit All , 2006, Epilepsy currents.
[86] E. S. Gibson,et al. Optogenetic Control of Synaptic Composition and Function , 2017, Neuron.
[87] Edward B. Miller,et al. α2,3 and α2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6 , 2006, Journal of Virology.
[88] Simon C Watkins,et al. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22 , 1996, Journal of virology.
[89] B. Bacskai,et al. Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer’s Disease , 2017, PloS one.
[90] Mufti Mahmud,et al. Differential Modulation of Excitatory and Inhibitory Neurons during Periodic Stimulation , 2016, Front. Neurosci..
[91] Sadegh Nabavi,et al. Engineering a memory with LTD and LTP , 2014, Nature.
[92] Simon R. Schultz,et al. Prospects for Optogenetic Augmentation of Brain Function , 2015, Front. Syst. Neurosci..
[93] G. Buzsáki,et al. Tools for probing local circuits: high-density silicon probes combined with optogenetics , 2015, Neuron.
[94] F. Bezanilla,et al. Photosensitivity of Neurons Enabled by Cell-Targeted Gold Nanoparticles , 2015, Neuron.
[95] J. Mittelstrass,et al. What is transdisciplinarity ? , 2003 .
[96] D.B. McCreery,et al. A characterization of the effects on neuronal excitability due to prolonged microstimulation with chronically implanted microelectrodes , 1997, IEEE Transactions on Biomedical Engineering.
[97] Bard Ermentrout,et al. Optogenetic Stimulation Shifts the Excitability of Cerebral Cortex from Type I to Type II: Oscillation Onset and Wave Propagation , 2017, PLoS Comput. Biol..
[98] K. Dikranian,et al. Surgical extraction of human dorsal root ganglia from organ donors and preparation of primary sensory neuron cultures , 2016, Nature Protocols.
[99] Kevin T. Beier,et al. A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins , 2017, Neuron.
[100] J. Sommer,et al. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. , 2006, Blood.
[101] Giovanni Di Pasquale,et al. Identification of PDGFR as a receptor for AAV-5 transduction , 2003, Nature Medicine.
[102] F. B. Johnson,et al. Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1 , 2006, Archives of Virology.
[103] Karl Deisseroth,et al. Optogenetics in Neural Systems , 2011, Neuron.
[104] W. Jagust,et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease , 2009, Neurology.
[105] Ahmed Soltan,et al. High density, high radiance μLED matrix for optogenetic retinal prostheses and planar neural stimulation , 2017, IEEE Transactions on Biomedical Circuits and Systems.
[106] V. Haurigot,et al. Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B. , 2010, Blood.
[107] Patrick Ruther,et al. Short and long term biocompatibility of NeuroProbes silicon probes , 2010, Journal of Neuroscience Methods.
[108] R. Samulski,et al. Viral vectors for gene delivery to the central nervous system , 2012, Neurobiology of Disease.
[109] Kristin N. Parent,et al. Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6 , 2010, Journal of Virology.
[110] Jie Tian,et al. Adenovirus Activates Complement by Distinctly Different Mechanisms In Vitro and In Vivo: Indirect Complement Activation by Virions In Vivo , 2009, Journal of Virology.
[111] D. Goldstein,et al. Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector. , 2003, Human gene therapy.
[112] Jie Tian,et al. Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[113] J. Brotchie,et al. High frequency stimulation or elevated K+ depresses neuronal activity in the rat entopeduncular nucleus , 2007, Neuroscience.
[114] A. Michael,et al. Brain Tissue Responses to Neural Implants Impact Signal Sensitivity and Intervention Strategies , 2014, ACS chemical neuroscience.
[115] Jing Wang,et al. A coaxial optrode as multifunction write-read probe for optogenetic studies in non-human primates , 2013, Journal of Neuroscience Methods.
[116] Robert Puers,et al. High-density optrode-electrode neural probe using SixNy photonics for in vivo optogenetics , 2015, 2015 IEEE International Electron Devices Meeting (IEDM).
[117] D. Shera,et al. Long-Term Follow-Up After Gene Therapy for Canavan Disease , 2012, Science Translational Medicine.
[118] P. Golshani,et al. WONOEP appraisal: Optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis , 2014, Epilepsia.
[119] T. Schlaepfer,et al. Integrative Neuroscience Mini Review Article Origin and Evolution of Deep Brain Stimulation , 2022 .
[120] Li Zhong,et al. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. , 2010, Human gene therapy.
[121] N. D. Di Paolo,et al. Recognition of virus infection and innate host responses to viral gene therapy vectors. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[122] M. Grubb,et al. Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability , 2010, Nature.
[123] J. Gordon,et al. Modeling the Spatiotemporal Dynamics of Light and Heat Propagation for In Vivo Optogenetics. , 2015, Cell reports.
[124] Rats can acquire conditional fear of faint light leaking through the acrylic resin used to mount fiber optic cannulas. , 2016, Learning & memory.
[125] E. Bamberg,et al. Optogenetic Control of Ca2+ and Voltage-Dependent Large Conductance (BK) Potassium Channels. , 2017, Journal of molecular biology.
[126] Susana Q. Lima,et al. Remote Control of Behavior through Genetically Targeted Photostimulation of Neurons , 2005, Cell.
[127] Ronald L Klein,et al. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[128] Lauren E. Mueller,et al. Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat , 2013, The European journal of neuroscience.
[129] D. Kleinfeld,et al. ReaChR: A red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation , 2013, Nature Neuroscience.
[130] Xue Han,et al. Prosthetic systems for therapeutic optical activation and silencing of genetically targeted neurons , 2008, SPIE BiOS.
[131] K. Deisseroth. Optogenetics: 10 years of microbial opsins in neuroscience , 2015, Nature Neuroscience.
[132] A. Benabid,et al. The impact on Parkinson’s disease of electrical parameter settings in STN stimulation , 2002, Neurology.
[133] M. Dours-Zimmermann,et al. Extracellular matrix of the central nervous system: from neglect to challenge , 2008, Histochemistry and Cell Biology.
[134] Application of optogenetics-mediated motor cortex stimulation in the treatment of chronic neuropathic pain. , 2016, Journal of translational science.
[135] E. Moser,et al. Relationship between neuronal activity and brain temperature in rats. , 1996, Neuroreport.
[136] A. Kleinschmidt,et al. Noninvasive Functional Imaging of Human Brain Using Light , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[137] S. Taverna,et al. Optogenetic activation of VGLUT2-expressing excitatory neurons blocks epileptic seizure-like activity in the mouse entorhinal cortex , 2017, Scientific Reports.
[138] S. Kochanek,et al. Frequency and Stability of Chromosomal Integration of Adenovirus Vectors , 1999, Journal of Virology.
[139] Nicholas B Langhals,et al. Providing a Sense of Touch to Prosthetic Hands , 2015, Plastic and reconstructive surgery.
[140] M. Welsh,et al. Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer* , 2001, The Journal of Biological Chemistry.
[141] J. Chiorini,et al. Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6 , 2010, Nature Medicine.
[142] Fred Wolf,et al. Controlling the oscillation phase through precisely timed closed-loop optogenetic stimulation: a computational study , 2013, Front. Neural Circuits.
[143] L. Rozamus,et al. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. , 2005, Blood.
[144] H. Lüders,et al. Deep Brain Stimulation in Epilepsy , 2001, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[145] P. Osborne. Problematizing Disciplinarity, Transdisciplinary Problematics , 2015, Theory, culture & society.
[146] J. Obeso,et al. Striatal activation by optogenetics induces dyskinesias in the 6‐hydroxydopamine rat model of Parkinson disease , 2017, Movement disorders : official journal of the Movement Disorder Society.
[147] E. Dietrichs,et al. Long-term follow-up of thalamic deep brain stimulation for essential tremor – patient satisfaction and mortality , 2014, BMC Neurology.
[148] K. Deisseroth,et al. eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications , 2008, Brain cell biology.
[149] R. Nicoll,et al. Single-Cell Optogenetic Excitation Drives Homeostatic Synaptic Depression , 2010, Neuron.
[150] S. Kleinlogel,et al. Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad , 2016, Cell Death & Disease.
[151] Mikhail G. Shapiro,et al. Infrared light excites cells by changing their electrical capacitance , 2012, Nature Communications.
[152] Keyun Qing,et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 , 1999, Nature Medicine.
[153] Jaimie M. Henderson,et al. Patient-specific analysis of the volume of tissue activated during deep brain stimulation , 2007, NeuroImage.
[154] S S Stensaas,et al. The reaction of the cerebral cortex to chronically implanted plastic needles. , 1976, Acta neuropathologica.
[155] G. Friehs,et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience , 2010, Molecular Psychiatry.
[156] Robert E. Gross,et al. Deep Brain Stimulation for the Treatment of Epilepsy: Circuits, Targets, and Trials , 2014, Neurotherapeutics.
[157] R. Samulski,et al. Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.
[158] Hisao Tsukamoto,et al. Homologs of vertebrate Opn3 potentially serve as a light sensor in nonphotoreceptive tissue , 2013, Proceedings of the National Academy of Sciences.
[159] Karen L. Smith,et al. Effects of insertion conditions on tissue strain and vascular damage during neuroprosthetic device insertion , 2006, Journal of neural engineering.
[160] A. Cavanna,et al. Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures , 2014, Neuropsychiatric disease and treatment.
[161] Jae-Woong Jeong,et al. Preparation and implementation of optofluidic neural probes for in vivo wireless pharmacology and optogenetics , 2017, Nature Protocols.
[162] Matthew D. Johnson,et al. Mechanisms and targets of deep brain stimulation in movement disorders , 2008, Neurotherapeutics.
[163] Elisa E. Konofagou,et al. Non-invasive, Focused Ultrasound-Facilitated Gene Delivery for Optogenetics , 2017, Scientific Reports.
[164] T. Oertner,et al. Optical induction of synaptic plasticity using a light-sensitive channel , 2007, Nature Methods.
[165] R A Bakay,et al. Ablative surgery and deep brain stimulation for Parkinson's disease. , 1999, Neurosurgery.
[166] S. Kochanek,et al. High-capacity 'gutless' adenoviral vectors. , 2001, Current opinion in molecular therapeutics.
[167] E. Agosin,et al. Optogenetic switches for light-controlled gene expression in yeast , 2017, Applied Microbiology and Biotechnology.
[168] The Activation Function of TMS on a Finite Element Model of a Cortical Sulcus , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[169] E. Ben-Menachem,et al. VNS Therapy versus the latest antiepileptic drug. , 2005, Epileptic disorders : international epilepsy journal with videotape.
[170] R. Mandel,et al. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. , 2007, Current gene therapy.
[171] Fabio Benfenati,et al. Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity , 2013, Front. Mol. Neurosci..
[172] Patrícia A. Correia,et al. Transient inhibition and long-term facilitation of locomotion by phasic optogenetic activation of serotonin neurons , 2017, eLife.
[173] P H Peckham,et al. Peripheral nerve stimulation for restoration of motor function. , 1997, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[174] H Bostock,et al. The strength‐duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. , 1983, The Journal of physiology.
[175] M. Kay,et al. The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 , 2006, Journal of Virology.
[176] M. Avoli,et al. Optogenetic Low-Frequency Stimulation of Specific Neuronal Populations Abates Ictogenesis , 2017, The Journal of Neuroscience.
[177] M. Rice,et al. Characterization of Optically and Electrically Evoked Dopamine Release in Striatal Slices from Digenic Knock-in Mice with DAT-Driven Expression of Channelrhodopsin , 2017, ACS chemical neuroscience.
[178] C B Maks,et al. Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[179] Philip J. Hahn,et al. Network perspectives on the mechanisms of deep brain stimulation , 2010, Neurobiology of Disease.
[180] R. Samulski,et al. Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity , 2002, Journal of Virology.
[181] Karl Deisseroth,et al. Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa , 2010, Science.
[182] W Zhang,et al. A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors. , 2000, Brain research. Molecular brain research.
[183] F. Bushman,et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.
[184] R. Campbell,et al. Emerging fluorescent protein technologies. , 2015, Current opinion in chemical biology.
[185] R. Herzog,et al. Hepatic gene transfer as a means of tolerance induction to transgene products. , 2009, Current gene therapy.
[186] K. Mathieson,et al. Optogenetic activation of neocortical neurons in vivo with a sapphire-based micro-scale LED probe , 2015, Front. Neural Circuits.
[187] Keyoumars Ashkan,et al. Accuracy of stimulating electrode placement in paediatric pallidal deep brain stimulation for primary and secondary dystonia , 2013, Acta Neurochirurgica.
[188] D. Szarowski,et al. Cerebral Astrocyte Response to Micromachined Silicon Implants , 1999, Experimental Neurology.
[189] M. Weitzman,et al. Adeno-associated virus biology. , 2011, Methods in molecular biology.
[190] Gonzalo Arias-Gil,et al. Measurement, modeling, and prediction of temperature rise due to optogenetic brain stimulation , 2016, Neurophotonics.
[191] G. Charras,et al. Optogenetic control of cellular forces and mechanotransduction , 2017, Nature Communications.
[192] J. Chiorini,et al. Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity , 2001, Journal of Virology.
[193] Seok Hyun Yun,et al. Light in diagnosis, therapy and surgery , 2016, Nature Biomedical Engineering.
[194] J. B. Ranck,et al. Which elements are excited in electrical stimulation of mammalian central nervous system: A review , 1975, Brain Research.
[195] K. Deisseroth,et al. Millisecond-timescale, genetically targeted optical control of neural activity , 2005, Nature Neuroscience.
[196] V. Dhawan,et al. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.
[197] Michael A. Henninger,et al. High-Performance Genetically Targetable Optical Neural Silencing via Light-Driven Proton Pumps , 2010 .
[198] T. Larcher,et al. Lack of immunotoxicity after regional intravenous (RI) delivery of rAAV to nonhuman primate skeletal muscle. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[199] Edward S Boyden,et al. Principles of designing interpretable optogenetic behavior experiments , 2015, Learning & memory.
[200] R. Kotin,et al. Immunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain , 2002, Journal of Virology.
[201] Volker Busskamp,et al. Biophysical Properties of Optogenetic Tools and Their Application for Vision Restoration Approaches , 2016, Front. Syst. Neurosci..
[202] K. Vonck,et al. Clinical experience with vagus nerve stimulation and deep brain stimulation in epilepsy. , 2007, Acta neurochirurgica. Supplement.
[203] I. Melnick,et al. Astrocytes and presynaptic plasticity in the striatum: Evidence and unanswered questions , 2018, Brain Research Bulletin.
[204] R. Samulski,et al. Viral vectors and delivery strategies for CNS gene therapy. , 2010, Therapeutic delivery.
[205] Svjetlana Miocinovic,et al. Experimental and theoretical characterization of the voltage distribution generated by deep brain stimulation , 2009, Experimental Neurology.
[206] J. Sommer,et al. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. , 2006, Blood.
[207] K. Ono,et al. Rapid and efficient gene delivery into the adult mouse brain via focal electroporation , 2016, Scientific Reports.
[208] D. I. Stephanova,et al. A distributed-parameter model of the myelinated human motor nerve fibre: temporal and spatial distributions of action potentials and ionic currents , 1995, Biological Cybernetics.
[209] Matthias Prigge,et al. Enhancing Channelrhodopsins: An Overview. , 2016, Methods in molecular biology.
[210] K. High,et al. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. , 2013, Blood.
[211] Alan McClelland,et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.
[212] C. Sladek,et al. Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellular neurosecretory neurons in the rat supraoptic nucleus , 2011, Journal of Neuroscience Methods.
[213] Matthew T. Kaufman,et al. An optogenetic toolbox designed for primates , 2011, Nature Neuroscience.
[214] Y. Agid,et al. Disappearance of parkinsonian signs after spontaneous vascular 'thalamotomy'. , 1986, Archives of neurology.
[215] R. Chen,et al. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. , 1999, Human gene therapy.
[216] J. A. Varela,et al. Shielded Coaxial Optrode Arrays for Neurophysiology , 2016, Front. Neurosci..
[217] Jacob G. Bernstein,et al. Millisecond-Timescale Optical Control of Neural Dynamics in the Nonhuman Primate Brain , 2009, Neuron.
[218] Alexander Gottschalk,et al. Optogenetic Long-Term Manipulation of Behavior and Animal Development , 2011, PloS one.
[219] A. Wise,et al. Challenges for the application of optical stimulation in the cochlea for the study and treatment of hearing loss , 2017, Expert opinion on biological therapy.
[220] Dimitri M. Kullmann,et al. Optogenetic approaches to treat epilepsy , 2016, Journal of Neuroscience Methods.
[221] B. Carter,et al. Adeno-associated virus vectors in clinical trials. , 2005, Human gene therapy.
[222] C. McIntyre,et al. Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation , 2016, Journal of neurochemistry.
[223] James L Olds,et al. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. , 1954, Journal of comparative and physiological psychology.
[224] G. Nagel,et al. Channelrhodopsin-2–XXL, a powerful optogenetic tool for low-light applications , 2014, Proceedings of the National Academy of Sciences.
[225] Claus-Peter Richter,et al. Optical cochlear implants: Evaluation of surgical approach and laser parameters in cats , 2010, Hearing Research.
[226] Dimiter Prodanov,et al. A model of space-fractional-order diffusion in the glial scar. , 2016, Journal of theoretical biology.
[227] Jason T. Ritt,et al. Control strategies for underactuated neural ensembles driven by optogenetic stimulation , 2013, Front. Neural Circuits.
[228] Ege Iseri,et al. Implantable optoelectronic probes for in vivo optogenetics , 2017, Journal of neural engineering.
[229] B. Davidson,et al. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. , 2008, Human gene therapy.
[230] Valentina Emiliani,et al. Computer Generated Holography with Intensity-Graded Patterns , 2016, Front. Cell. Neurosci..
[231] R. Samulski,et al. Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood-Brain Barrier (BBB). , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[232] Nader Pouratian,et al. Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies , 2016, Front. Neurosci..
[233] B. Connors,et al. Semiconductor ultra-violet light-emitting diodes for flash photolysis , 2007, Journal of Neuroscience Methods.
[234] Mary Collins,et al. One Contribution to the Special Feature 'evolution and Genetics in Medicine' Guest Edited Gene Therapy: Progress and Predictions , 2022 .
[235] Sohee Kim,et al. Characterization of fiber-optic light delivery and light-induced temperature changes in a rodent brain for precise optogenetic neuromodulation. , 2016, Biomedical optics express.
[236] David Eidelberg,et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial , 2007, The Lancet.
[237] A. Malyshev,et al. Chloride conducting light activated channel GtACR2 can produce both cessation of firing and generation of action potentials in cortical neurons in response to light , 2017, Neuroscience Letters.